Acne vulgaris affects an estimated 9.4 percent of the global population, making it the eighth most prevalent disease in the world, and the most recent Global Burden of Disease modelling counts roughly 231 million people living with it in a single year.

Key findings

  • 9.4 percent of the world has acne. Acne vulgaris is estimated to affect 9.4 percent of the global population, ranking it the eighth most prevalent disease worldwide (Tan and Bhate, 2015, from GBD 2010).
  • 231.2 million prevalent cases in one year. The Global Burden of Disease Study 2019 estimated 231.2 million prevalent cases of acne vulgaris worldwide (95% uncertainty interval 208.2 to 255.5 million).
  • The burden is rising, not fading. Global prevalent cases rose roughly 48 percent between 1990 and 2019.
  • It peaks in the teens. Prevalence peaks in the 15 to 19 age band; new cases peak earlier, at ages 10 to 14 (GBD 2019).
  • Women carry more of it. The age-standardised rate among women is about 1.3 times that of men, though the gap is narrowing as rates rise faster in men (GBD 2019).
  • Highest rates sit in high-income regions. Age-standardised rates were highest in high-income regions, while the steepest increases were in lower-income regions (GBD 2019).

Global prevalence

The headline figure for acne is stable across the literature. Acne vulgaris affects an estimated 9.4 percent of the global population, a figure that places it as the eighth most prevalent disease worldwide. That estimate, widely cited across dermatology, traces to the Global Burden of Disease Study 2010, in which skin conditions collectively ranked as the fourth leading cause of nonfatal disease burden and acne sat among the ten most prevalent diseases on Earth.

The most recent full modelling sharpens the picture. The Global Burden of Disease Study 2019 estimated 231.2 million prevalent cases of acne vulgaris in a single year (95% uncertainty interval 208.2 to 255.5 million), alongside 117.4 million incident, or new, cases. Acne is not a cosmetic footnote. It is a measurable, ranked contributor to global disease burden.

The burden is growing

Acne is becoming more common, not less. Between 1990 and 2019, global prevalent cases rose by approximately 48 percent. Even after adjusting for a larger, older world, a person today is modestly more likely to have acne than a person in 1990. The condition is expanding its footprint at both the absolute and the structural level.

Peak age

Acne is, first and foremost, a condition of adolescence. Across the GBD modelling, prevalence peaks in the 15 to 19 year age band. Incidence, the rate of new cases appearing, peaks slightly earlier, in the 10 to 14 year band, consistent with onset clustering around the start of puberty. New cases arrive first in early adolescence, then accumulate into a peak prevalence in the late teens before declining through the twenties.

This is why demand for acne care concentrates so tightly in a narrow age window, and why that window has outsized cultural reach: the peak-prevalence cohort overlaps almost exactly with the most active demographic on social platforms.

Sex differences

The sex pattern in acne has two layers that point in opposite directions depending on age. In the GBD 2019 modelling, the age-standardised rate among women was around 1.3 times that of men. Women carry more of the measured burden overall, a pattern reinforced by the persistence of acne into adult life among women. The picture inverts in severity and early adolescence, where acne is most common in postpubescent teens and boys are most frequently affected by more severe forms. The aggregate gap between women and men is also narrowing, because rates have risen faster in men.

Geography

Acne is genuinely global, but it is not evenly distributed. In the GBD 2019 analysis, age-standardised rates were highest in high-income regions. The interpretation requires care: part of that gradient reflects real differences in exposure and lifestyle, and part reflects ascertainment, since high-income health systems detect, code, and report acne more completely. The more dynamic signal is in the trend, where the increase in age-standardised rates was more pronounced outside high-income regions, meaning the geography of acne burden is flattening over time as lower-income regions converge upward.

The demand layer

Underneath the disease map sits a consumer-demand map, and the two are tightly coupled. The peak-prevalence cohort, teenagers and young adults, is also the cohort that searches, posts, and purchases most actively online. Over the past several years, public interest in at-home acne care, particularly hydrocolloid pimple patches and topical actives such as salicylic acid and benzoyl peroxide, has broadened from a niche into a mainstream category, propelled by social video and Korean-beauty crossover. A precise, reproducible search-interest index by term and region is a planned phase-2 addition to this report; this edition anchors the disease map and reports the demand direction qualitatively rather than with unverified figures.

Methodology and sources

Sources. (1) Global Burden of Disease Study 2019, as analysed by Chen et al., British Journal of Dermatology, 2022, for prevalent and incident cases, the temporal trend, the sex ratio, and the regional gradient. (2) Global Burden of Disease Study 2010, as analysed by Hay et al., Journal of Investigative Dermatology, 2014, the primary source for the 9.4 percent prevalence and the top-ten disease ranking. (3) Tan and Bhate, British Journal of Dermatology, 2015, the review stating the 9.4 percent and eighth-most-prevalent figures and the boys-more-severe pattern. (4) Wang et al., Frontiers in Medicine, 2022, a GBD 2019 analysis corroborating the 15 to 19 peak-prevalence and 10 to 14 peak-incidence age bands.

Years. Prevalence and burden figures reflect GBD 2019 (reference year 2019) and GBD 2010 (reference year 2010). Citations span 2014 to 2022.

Extraction date. All figures retrieved and verified on 10 June 2026.

Cited vs derived. All headline figures are cited directly from primary or peer-reviewed sources; no figure is computed or estimated by us. The demand layer is described qualitatively; no search-interest percentages are reported because none could be verified for this edition.

Limitations. GBD figures are modelled estimates with uncertainty intervals, not direct case counts. Geographic differences partly reflect detection and reporting, not only true prevalence. The 9.4 percent prevalence reflects GBD 2010 while the 231.2 million case count reflects GBD 2019, so the two are complementary rather than a single time point. This report is educational and is not medical advice.

Cite this report

Plain: TheBeautyGPT, “The State of Skin 2026: The Acne Index,” published 10 June 2026. https://thebeautygpt.com/reports/state-of-skin-2026

APA: TheBeautyGPT. (2026, June 10). The state of skin 2026: The acne index. https://thebeautygpt.com/reports/state-of-skin-2026